Patent application number | Description | Published |
20080207728 | BICYCLIC ACYLTRYPTOPHANOLS - The present invention relates to acyltryptophanols of the general formula I, | 08-28-2008 |
20080221195 | 1,2-DIARYLACETYLENE DERIVATIVES OF ACYLTRYPTOPHANOLS - The present invention relates to acyltryptophanols of the general formula I, | 09-11-2008 |
20080255117 | SULFONYLTRYPTOPHANOLS - The present invention relates to sulfonyltryptophanols of the general formula I, | 10-16-2008 |
20080275083 | 2,3,4,9-TETRAHYDRO-1H-CARBAZOLES - The present invention relates to 2,3,4,9-tetrahydro-1H-carbazoles of the general formula I, | 11-06-2008 |
20080287493 | ARYLMETHYLEN SUBSTITUTED N-ACYL-Y-AMINOALCOHOLS - The present invention relates to arylmethylen substituted N-acyl-Y-aminoalcohols of the general formula I | 11-20-2008 |
20090023738 | DIAMINOPYRIMIDINES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to diaminopyrimidines of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP | 01-22-2009 |
20090023741 | ARYL/HETARYLAMIDES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to aryl/hetarylamide derivatives of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP | 01-22-2009 |
20090042878 | THIENOPYRIMIDYLAMINES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to thienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP | 02-12-2009 |
20090042882 | SUBSTITUTED ACETAMIDES AS MODULATORS OF THE EP2 RECEPTOR - The present invention relates to substituted acetamides of the general formula I, process for their preparation, and the use thereof for the manufacture of pharmaceutical compositions for the treatment of disorders and indications connected with the EP | 02-12-2009 |
20090042913 | Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor - The present invention relates to indolylalkylthienopyrimidylamines of the general formula I, to processes for their preparation and to their use for production of pharmaceutical compositions for treatment of disorders and indications connected to the EP | 02-12-2009 |
20090069321 | CYANOMETHYL SUBSTITUTED N-ACYL TRYPTAMINES - The present invention relates to cyanomethyl substituted N-acyl tryptamines of the formula I | 03-12-2009 |
20090069328 | ALPHA-ALKYL SUBSTITUTED N-ACYLTRYPTOPHANOLS - The present invention relates to α-alkyl substituted N-acyltryptophanols of the formula I | 03-12-2009 |
20090075987 | ALKYLACETYLENE SUBSTITUTED ACYLTRYPTOPHANOLS - The present invention relates to acyltryptophanols of the general formula I, | 03-19-2009 |
20090082328 | Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity - This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 03-26-2009 |
20090082372 | Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols - The present invention relates to arylmethylene substituted N-Acyl-β-amino alcohols of the formula I | 03-26-2009 |
20100029599 | Indolylamides as modulators of the EP2 receptor - The present invention relates to indolylamide derivatives of the general formula (I), to processes for preparation thereof and to use thereof for production of pharmaceutical compositions for treatment of disorders and indications associated with the EP | 02-04-2010 |
20110071125 | SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY - This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 03-24-2011 |
20120128662 | SUBSTITUTED IMIDAZOQUINOXALINES - The present invention relates to substituted imidazoquinoxaline compounds of general formula (I) as inhibitors of Mps-1 Kinase or TTK, and being active against inflammation and cancer. | 05-24-2012 |
20120263708 | SUBSTITUTED AMINOQUINOXALINES AS TYROSINE THREONINE KINASE INHIBITORS - The present invention relates to substituted aminoquinoxaline compounds of general formula (I) in which (II), R | 10-18-2012 |
20120328610 | TRIAZOLOPYRIDINES - The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: Formula (I), in which R | 12-27-2012 |
20120328611 | SUBSTITUTED TRIAZOLOPYRIDINES - The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors: Formula (I), in which R | 12-27-2012 |
20130121994 | TRIAZOLOPYRIDINE DERIVATIVES - The present invention relates to triazolopyridine compounds of general formula (I) which are Monopolar Spindle 1 kinase (Mps-1 or TTK) inhibitors in which R | 05-16-2013 |
20130156756 | Substituted Triazolopyridines - The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R | 06-20-2013 |
20130195848 | IMIDAZOPYRAZINES - The present invention relates to imidazopyrazine compounds of general Formula (I): in which X, R | 08-01-2013 |
20130210815 | SUBSTITUTED IMIDAZOPYRAZINES - The present invention relates to substituted imidazopyrazine compounds of general formula (I) in which A, R | 08-15-2013 |
20130267527 | SUBSTITUTED 6-IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS - The present invention relates to substituted imidazopyrazine compounds of general formula (I), in which R | 10-10-2013 |
20130281460 | 6-THIO-SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS - The present invention relates to substituted imidazopyrazine compounds of general formula (I): (I) in which R | 10-24-2013 |
20130303532 | IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS - The present invention relates to substituted imidazopyrazine compounds of general formula (I): in which R | 11-14-2013 |
20130338133 | SUBSTITUTED IMIDAZOPYRIDAZINES - The present invention relates to substituted imidazopyridazine compounds of general formula (I), which are Mps-1 (Monopolar Spindle 1) Kinase inhibitors (also known as Tyrosine Threonine Kinase, TTK) in which R | 12-19-2013 |
20140135319 | 6-SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS - The present invention relates to substituted imidazopyrazine compounds of general formula (I): in which R | 05-15-2014 |
20140187548 | 6 SUBSTITUTED IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS - The present invention relates to substituted imidazopyrazine compounds of general formula (I) in which R | 07-03-2014 |
20140255392 | SUBSTITUTED IMIDAZOPYRIDINES AND INTERMEDIATES THEREOF - The present invention relates to substituted imidazopyridine compounds of general formula (I) in which R | 09-11-2014 |
20140302010 | SUBSTITUTED BENZIMIDAZOLES - The present invention relates to substituted benzimidazole compounds of general formula (I) in which R | 10-09-2014 |